Add Company
Join Now

Biosion Revenue and Competitors

License our Company Data API

Nanjing, cn

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Biosion has 22 Employees.(i)
  • Biosion grew their employee count by -12% last year.

Biosion's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A775%N/AN/A
#2
N/A80%N/AN/A
#3
N/A5-17%N/AN/A
#4
N/A717%N/AN/A
#5
N/A16-6%N/AN/A
#6
N/A433%N/AN/A
#7
N/A22-12%N/AN/A
#8
N/A525%N/AN/A
#9
N/A462%N/AN/A
#10
N/A1525%N/AN/A
Add Company

What Is Biosion?

Biosion is a global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Established in 2017, Biosion has built a pipeline of innovative biologics through its internally derived technologies including the H³ antibody discovery, SynTracer™ HT-endocytosis and Flexibody™ bispecific platforms. Biosion’s lead asset, BSI-045B (anti-TSLP mAb), is currently in phase 1 clinical trials for atopic dermatitis and severe asthma. Biosion and partners have plans to progress additional assets into the clinic for oncology indications over the next year. Biosion has operations in the US, Australia, and China. To learn more about Biosion visit www.biosion.com.

keywords:N/A

N/A

Total Funding

22

Number of Employees

N/A

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M225%N/A
#2
N/A380%N/A
#3
$6.4M39-11%N/A
#4
$8.6M4014%N/A
#5
N/A415%N/A